trending Market Intelligence /marketintelligence/en/news-insights/trending/0nrirjzob8v0do2lqwjy_q2 content esgSubNav
In This List

Valeant launches $1.25B senior notes offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Valeant launches $1.25B senior notes offering

Valeant Pharmaceuticals International Inc. is looking to issue $1.25 billion in fresh debt to repurchase some of its existing notes.

The Canadian specialty drugmaker will price the offering at a later date. The company is looking to repurchase its existing 6.375% senior notes due 2020, 5.375% senior notes due 2020, and up to $100.0 million principal amount of its 6.750% senior notes due 2021.

The tender offer to repurchase the notes expires 11:59 p.m. ET on April 9.